Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chlormethine gel skin reaction study in early-stage mycosis fungoides
2019-004891-20Phase 2Terminated
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of mechlorethamine in mycosis fungoides (MF) and cutaneous T-cell lymphoma (CTCL) (2 arms), sponsored by European Organisation for Research and Treatment of Cancer. Started Dec 2020; status: terminated.
02
Drugs
mechlorethamine
03
Conditions
mycosis fungoides (MF)cutaneous T-cell lymphoma (CTCL)
Beyond the preview
Go deeper on 2019-004891-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004891-20.